Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Conditions
Cancer - Dermatologic Conditions
Conditions: official terms
Disease - Skin Diseases
Conditions: Keywords
Quality of Life (QoL), Assessment, 14-236, Patients and Survivors
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case-Only, Time Perspective: Prospective
Intervention
Name: Quality of Life (QoL) Assessment
Type: Behavioral
Overall Status
Recruiting
Summary
The purpose of this study is to see how skin conditions that are related to different kinds of cancer or cancer treatments affect a patient's overall well-being. Skin conditions are common in cancer patients and survivors. Sometimes, the skin condition is directly related to the cancer. Other times, these conditions are a side effect of cancer treatment. Patients in the study will be asked to fill out at least one questionnaire about how they feel about their skin condition. If the patient needs to be treated for their skin condition, they will be asked to complete the same questionnaire when they return for a follow-up visit. The investigators hope the study will improve our understanding of how cancer patients feel about their skin conditions. They also hope this study helps them learn how to improve the way we treat skin conditions in cancer patients.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 3 Years
Gender: Both
Criteria: Inclusion Criteria:

- Cancer patients and survivors with a pre-existing dermatologic condition related to their underlying disease or completed/ongoing therapy for cancer, who present for assessment/management of their skin condition.

- Male or female patients at least 3 years and older who are able to speak/read English and provide written informed consent

- NOTE: Informed Consent guidelines will be followed for minors

- First grade adult family members, spouses, and caregivers of patients with a Grade 3 dermatologic condition related to their primary cancer or cancer treatment who are able to speak/read English and provide written informed consent may complete the family DLQI questionnaire

Exclusion Criteria:

- Inability to read and/or speak English

- Cognitive or psychiatric deficit resulting in an inability to provide written informed consent
Location
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Status: Recruiting
Contact: Mario Lacouture, MD - 646-888-6014
Start Date
November 2014
Sponsors
Memorial Sloan Kettering Cancer Center
Source
Memorial Sloan Kettering Cancer Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page